689018 |
FRONTIERS IN ONCOLOGY |
Investigating 18F-FDG PET/CT Parameters as Prognostic Markers for Differentiated Thyroid Cancer: A Systematic Review |
2021-05-13 |
10.3389/fonc.2021.648658 |
Wang Hongxi, Dai Hongyuan, Li Qianrui, Shen Guohua, Shi Lei, Tian Rong |
689017 |
FRONTIERS IN ONCOLOGY |
Combined Radiochemotherapy: Metalloproteinases Revisited |
2021-05-13 |
10.3389/fonc.2021.676583 |
Waller Verena, Pruschy Martin |
689016 |
FRONTIERS IN ONCOLOGY |
Carnosol Is a Novel Inhibitor of p300 Acetyltransferase in Breast Cancer |
2021-05-13 |
10.3389/fonc.2021.664403 |
Alsamri Halima, Hasasna Hussain El, Baby Bincy, Alneyadi Aysha, Dhaheri Yusra Al, Ayoub Mohammed Akli, Eid Ali H., Vijayan Ranjit, Iratni Rabah |
689015 |
FRONTIERS IN ONCOLOGY |
Ancient Adversary – HERV-K (HML-2) in Cancer |
2021-05-13 |
10.3389/fonc.2021.658489 |
Dervan Eoin, Bhattacharyya Dibyangana D., McAuliffe Jake D., Khan Faizan H., Glynn Sharon A. |
689014 |
FRONTIERS IN ONCOLOGY |
Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer |
2021-05-13 |
10.3389/fonc.2021.619893 |
Zheng Zongtai, Xu Feijia, Gu Zhuoran, Yan Yang, Xu Tianyuan, Liu Shenghua, Yao Xudong |
689013 |
FRONTIERS IN ONCOLOGY |
Repurposing Infectious Diseases Vaccines Against Cancer |
2021-05-13 |
10.3389/fonc.2021.688755 |
Vandeborne Liese, Pantziarka Pan, Van Nuffel An M. T., Bouche Gauthier |
689012 |
FRONTIERS IN ONCOLOGY |
Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy |
2021-05-13 |
10.3389/fonc.2021.677609 |
Luo De, Kuang Fei, Du Juan, Zhou Mengjia, Peng Fangyi, Gan Yu, Fang Cheng, Yang Xiaoli, Li Bo, Su Song |
689011 |
FRONTIERS IN ONCOLOGY |
Case Report: 18F-PSMA PET/CT May Improve the Clinical Management of Penile Metastases From Prostate Cancer |
2021-05-13 |
10.3389/fonc.2021.683343 |
Fan Junjie, Liang Hua, Zhang Xing, Chen Xingfa, Duan Xiaoyi, Li Lei, He Dalin, Wu Kaijie |
689010 |
FRONTIERS IN ONCOLOGY |
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab |
2021-05-13 |
10.3389/fonc.2021.635096 |
Pogorzelski Michael, Hilser Thomas, Ting Saskia C., Kansy Benjamin, Gauler Thomas C., Stuschke Martin, Schmid Kurt W., Lang Stephan, Grünwald Viktor, Schuler Martin, Kasper Stefan |
689009 |
FRONTIERS IN ONCOLOGY |
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells |
2021-05-13 |
10.3389/fonc.2021.646971 |
Shorer Arbel Yamit, Katz Ben-Zion, Gabizon Ronen, Shraga Amit, Bronstein Yotam, Kamdjou Talia, Globerson Levin Anat, Perry Chava, Avivi Irit, London Nir, Herishanu Yair |